WeightWatchers' CEO said on Wednesday it planned to offer Novo Nordisk's much-anticipated Wegovy in pill form if it is ...

Personal wellness company WeightWatchers (NASDAQ:WW) announced better-than-expected revenue in Q3 CY2025, but sales fell by ...

WeightWatchers has revealed plans to offer Novo Nordisk 's highly anticipated obesity drug, Wegovy, in its pill form, should ...

Constantly keeping up with the times and the latest science, WeightWatchers, or WW, has updated its program yet again—including making its offerings accessible to more people. Whether you’re already a ...

WeightWatchers plans to offer Novo Nordisk's Wegovy as a pill in the U.S. next year, enhancing their partnership. This move ...

WeightWatchers aims to expand its market by offering a pill version of Novo Nordisk's weight-loss drug, Wegovy, next year.

End of Period Subscribers of 3.0 million, including Clinical Subscribers of 124 thousand Total Revenues of $172 million; Clinical Subscription Revenues of $26 million, up 35% year-over-year Net Loss ...

Detailed price information for Ww International Inc (WW-Q) from The Globe and Mail including charting and trades.

In today’s Pharmaceutical Executive Daily, WeightWatchers plans to offer Novo Nordisk’s oral Wegovy pending FDA approval, FDA ...

WeightWatchers, a company that started with one housewife in New York and grew to be the biggest company of its kind, is filing for Chapter 11 bankruptcy. CEO Tara Comonte said the company’s more than ...

WW International and advisors to its lenders have reportedly taken a step in talking about potentially restructuring the company’s debt. The Wall Street Journal reported, citing unnamed sources, that ...

Officials with Weight Watchers at the Louetta Road location confirmed with Community Impact that the business has relocated. Health and Wellness Coach Kim Henson said the business moved from the ...